Dovato is used to treat HIV-1 infections in adults with no ARV treatment history or to replace the current antiretroviral treatment in those who are virologically suppressed (HIV-1 levels are at an undetectable level, or HIV-1 RNA (meaning viral load) is less than 50 copies per milliliter) on a stable ARV regimen with no history of treatment failure and no known drug substitutions associated with resistance to the individual ingredients of Dovato.